コンテンツへスキップ
Merck

860543P

Avanti

C12 Glucosyl(β) Ceramide (d18:1/12:0)

Avanti Research - A Croda Brand

別名:

D-glucosyl-β-1,1′-N-lauroyl-D-erythro-sphingosine

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

実験式(ヒル表記法):
C36H69NO8
CAS番号:
分子量:
643.93
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


製品名

C12 Glucosyl(β) Ceramide (d18:1/12:0), Avanti Research - A Croda Brand 860543P, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 5 mg (860543P-5mg)

manufacturer/tradename

Avanti Research - A Croda Brand 860543P

lipid type

sphingolipids

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O

InChI

1S/C36H69NO8/c1-3-5-7-9-11-13-14-15-16-18-19-21-23-25-30(39)29(28-44-36-35(43)34(42)33(41)31(27-38)45-36)37-32(40)26-24-22-20-17-12-10-8-6-4-2/h23,25,29-31,33-36,38-39,41-43H,3-22,24,26-28H2,1-2H3,(H,37,40)/b25-23+/t29-,30+,31?,33+,34?,35?,36+/m0/s1

InChI key

IYCYEZLMOLRFAN-QGJHTTTBSA-N

Application

C12 Glucosyl(β) Ceramide (d18:1/12:0) or D-glucosyl-β-1,1′-N-lauroyl-D-erythro-sphingosine has been used in lipid binding assay to assess the binding of monoclonal antibodies (mAbs). It may be used as an internal standard to spike cell lysate and to quantify lipid species using fourier transform mass spectrometry (FTMS) analysis. It may also be used as an internal standard for lipid extraction in U87MG (human glioma cell line).

Packaging

5 mL Amber Glass Screw Cap Vial (860543P-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


保管分類

11 - Combustible Solids

wgk

WGK 3



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 資料 section.

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする



Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
Hernandez-Tiedra S, et al.
Autophagy, 12(11), 2213-2229 (2016)
Shelly J Krebs et al.
Immunity, 50(3), 677-691 (2019-03-17)
Lineage-based vaccine design is an attractive approach for eliciting broadly neutralizing antibodies (bNAbs) against HIV-1. However, most bNAb lineages studied to date have features indicative of unusual recombination and/or development. From an individual in the prospective RV217 cohort, we identified
David B Iaea et al.
Biochimica et biophysica acta. Molecular and cell biology of lipids, 1865(4), 158609-158609 (2020-01-10)
STARD4, a member of the evolutionarily conserved START gene family, is a soluble sterol transport protein implicated in cholesterol sensing and maintenance of cellular homeostasis. STARD4 is widely expressed and has been shown to transfer sterol between liposomes as well